Although D-dimer results within a typical range can rule out pulmonary embolism, high results alone can’t diagnose this condition. Doctors usually need to run extra tests to make a diagnosis. A ...

Clinicians are reminded to include non-prescription supplement history when evaluating thrombotic events in younger adults ...

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ADJUST-DVT trial. For patients ages 50 and older with a nonhigh or unlikely ...

Does an elevated ultrasensitive D-dimer level in a patient whose pre-test probability puts him at low risk for pulmonary embolus (PE) indicate an increased risk for PE or deep venous thrombosis (DVT)?

The investigation included 2993 CTPAs in 2655 patients over an approximately 2.5-year period. The authors compared the diagnostic yield of the override group (563 CTPAs in patients with a Wells score ...

D-dimer plus multidetector CT (D-dimer/CT) is as effective as D-dimer/CT plus venous compression ultrasound (US) for identifying pulmonary embolism (PE) and short-term risk of thromboembolic events in ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

Combination of bevacizumab (B) plus immunotherapy, with interleukin-2 (IL-2) and interferon-α (IFN-α) plus chemotherapy (BIC) in patients with metastatic renal cell cancer (mRCC): Dose-finding phase ...